The World Health Organization unveiled a six-month plan to contain a current Bundibugyo Ebola outbreak in Africa, including scaling point-of-care molecular diagnostics and strengthening reference laboratory capacity. WHO said the overall investment is about $518 million, with partners including Africa CDC, FIND, Unitaid, and local governments. Central to the plan is expanding use of a point-of-care PCR system from KH Medical, alongside improved diagnostic testing and sequencing-based surveillance. WHO officials said case counts already exceed previous Bundibugyo outbreak totals at similar milestones, highlighting the operational urgency for faster detection. Separately, Roche announced it developed a research-use-only PCR test to detect Bundibugyo Ebola virus, supporting response efforts while commentary in The Lancet underscored that missing or unreliable testing can obscure the scale and transmissibility of the epidemic.